State Street’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.47M | Buy |
1,008,909
+747,126
| +285% | +$4.79M | ﹤0.01% | 2824 |
|
|
2025
Q1 | $927K | Buy |
261,783
+43,400
| +20% | +$154K | ﹤0.01% | 3444 |
|
|
2024
Q4 | $825K | Buy |
218,383
+63,475
| +41% | +$240K | ﹤0.01% | 3522 |
|
|
2024
Q3 | $502K | Hold |
154,908
| – | – | ﹤0.01% | 3595 |
|
|
2024
Q2 | $294K | Sell |
154,908
-1,905,134
| -92% | -$3.62M | ﹤0.01% | 3706 |
|
|
2024
Q1 | $5.85M | Buy |
2,060,042
+618,640
| +43% | +$1.76M | ﹤0.01% | 2862 |
|
|
2023
Q4 | $21.2M | Buy |
1,441,402
+201,649
| +16% | +$2.97M | ﹤0.01% | 2178 |
|
|
2023
Q3 | $22.7M | Buy |
1,239,753
+82,054
| +7% | +$1.5M | ﹤0.01% | 2102 |
|
|
2023
Q2 | $25M | Buy |
1,157,699
+91,461
| +9% | +$1.97M | ﹤0.01% | 2107 |
|
|
2023
Q1 | $31.3M | Sell |
1,066,238
-9,374
| -0.9% | -$275K | ﹤0.01% | 1943 |
|
|
2022
Q4 | $39.7M | Buy |
1,075,612
+248,544
| +30% | +$9.18M | ﹤0.01% | 1788 |
|
|
2022
Q3 | $23.3M | Buy |
827,068
+630,603
| +321% | +$17.8M | ﹤0.01% | 2109 |
|
|
2022
Q2 | $3.78M | Buy |
196,465
+97,253
| +98% | +$1.87M | ﹤0.01% | 3236 |
|
|
2022
Q1 | $1.28M | Buy |
+99,212
| New | +$1.28M | ﹤0.01% | 3730 |
|